PRDM14 and breast carcinoma: Although PRDM14 and PRDM7 were also among the HMTs with the highest frequency of amplification or homozygous deletion, respectively, in breast cancer, they were excluded from the qRT-PCR analysis because their expression levels in breast cancer cells were too low for detection (data not shown).